Cytokine “storm”, cytokine “breeze”, or both in COVID-19?
- 26 November 2020
- journal article
- editorial
- Published by Walter de Gruyter GmbH in cclm
- Vol. 59 (4), 637-639
- https://doi.org/10.1515/cclm-2020-1761
Abstract
Article Cytokine “storm”, cytokine “breeze”, or both in COVID-19? was published on 03 Dec 2020 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (, Ahead of Print).Keywords
This publication has 14 references indexed in Scilit:
- Hemocytometric characteristics of COVID-19 patients with and without cytokine storm syndrome on the sysmex XN-10 hematology analyzercclm, 2020
- Cytokine Levels in Critically Ill Patients With COVID-19 and Other ConditionsJAMA, 2020
- Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromesThe Lancet Respiratory Medicine, 2020
- Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational studyThe Lancet Respiratory Medicine, 2020
- Highly Sensitive Quantification of Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Sheds Light on its Potential Clinical ValueClinical Infectious Diseases, 2020
- COVID-19: unravelling the clinical progression of nature’s virtually perfect biological weaponAnnals of Translational Medicine, 2020
- Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysiscclm, 2020
- Coronavirus disease 2019 (COVID-19): the portrait of a perfect stormAnnals of Translational Medicine, 2020
- COVID-19: consider cytokine storm syndromes and immunosuppressionThe Lancet, 2020
- Cytokine release syndromeJournal for ImmunoTherapy of Cancer, 2018